Advertisement

Erectile Dysfunction: Identification, Assessment, Treatment, and Follow-Up

  • Penny Kaye JensenEmail author
  • Jeffrey A. Albaugh
Chapter

Abstract

Understand the incidence, prevalence, etiology, and risk factors associated with erectile dysfunction.

Keywords

Erectile Dysfunction Radical Prostatectomy Nurse Practitioner Erectile Function American Urologic Association 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Akpunona AZ, Mutgi AB, Federman DJ (1994) Routine prolactin measurement is not necessary in the initial evaluation of male impotence. J Gen Intern Med 9:336–338CrossRefGoogle Scholar
  2. Albaugh JA, Ferrans CE (2010) Impact of penile injections on men with erectile dysfunction after prostatectomy. Urol Nurs 30(1):64–77PubMedGoogle Scholar
  3. Albaugh J, Amargo I, Capelson R, Flaherty E, Forest C, Goldstein I, Jensen PK, Jones K, Kloner R, Lewis J, Mullin S, Payton T, Rines B, Rosen R, Sadovsky R, Snow K, Vetrosky D, University of Medicine and Dentistry of New Jersey (2002) Health care clinicians in sexual health medicine: focus on erectile dysfunction. Urol Nurs 22(4):217–231; quiz 232PubMedGoogle Scholar
  4. American Urological Association (2005) Management of erectile dysfunction, 3rd edn. Retrieved 15 Oct 2015, from http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines.cfm?sub=ed
  5. Andersen I, Heitmann BL, Wagner G (2008) Obesity and sexual dysfunction in younger Danish men. J Sex Med 5(9):2053–2060. doi: 10.1111/j.1743-6109.2008.00920.x CrossRefPubMedGoogle Scholar
  6. Androshchuk V, Pugh N, Wood A, Ossei-Gerning N (2015) Erectile dysfunction: a window to the heart. BMJ Case Rep. doi: 10.1136/bcr-2015-210124
  7. Annon JS (1974) The behavioral treatment of sexual problems, 1st edn. Kapiolani Health Services, HonoluluGoogle Scholar
  8. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB (1998) The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 60(4):458–465CrossRefPubMedGoogle Scholar
  9. Auxillium Pharmaceuticals Inc. (2011) Edex. Retrieved 2015, from http://www.edex.com/_assets/pdf/prescribing_information.pdf
  10. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2003) Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139(3):161–168CrossRefPubMedGoogle Scholar
  11. Billups K, Friedrich S (2005) Assessment of fasting lipid panels and Doppler ultrasound testing in men presenting with erectile dysfunction and no other medical problem. Am J Cardiol 96(Suppl):57M–61MCrossRefPubMedGoogle Scholar
  12. Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2(1):40–50. doi: 10.1111/j.1743-6109.2005.20104_1.x; discussion 50–52CrossRefPubMedGoogle Scholar
  13. Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA (2008) Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res 20(3):236–242. doi: 10.1038/sj.ijir.3901634 CrossRefPubMedGoogle Scholar
  14. Blander DS, Sanchez-Ortiz RF, Wein AJ, Broderick GA (2000) Efficacy of sildenafil in erectile dysfunction after radical prostatectomy. Int J Impot Res 12(3):165–168CrossRefPubMedGoogle Scholar
  15. Boyle P (1999) Epidemiology of erectile dysfunction. In: Carson C, Kirby RS, Goldstein I (eds) Textbook of erectile dysfunction. ISIS Medical Media, Oxford, pp 15–29Google Scholar
  16. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH (2003) Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey”. Eur Urol 44(5):588–594CrossRefPubMedGoogle Scholar
  17. Cappelleri JC, Rosen RC (2005) The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 17(4):307–319. doi: 10.1038/sj.ijir.3901327 CrossRefPubMedGoogle Scholar
  18. Carson C, McMahon C (2008) Fast facts: erectile dysfunction, 4th edn. Health Press, OcfordGoogle Scholar
  19. Carson CC, Hatzichristou DG, Carrier S, Lording D, Lyngdorf P, Aliotta P, Auerbach S, Murdock M, Wilkins HJ, McBride TA, Colopy MW, Patient Response with Vardenafil in Slidenafil Non-Responders Study Group (2004) Erectile response with vardenafil in sildenafil nonresponders: a multicentre, double-blind, 12-week, flexible-dose, placebo-controlled erectile dysfunction clinical trial. BJU Int 94(9):1301–1309. doi: 10.1111/j.1464-410X.2004.05161.x CrossRefPubMedGoogle Scholar
  20. Carson CC, Kirby RS, Goldstein I, Wyllie MG (eds) (2009) Textbook of erectile dysfunction, 2nd edn. Informa Healthcare, New YorkGoogle Scholar
  21. Cherry DK, Woodwell DA (2002) National ambulatory medical care survey: 2000 summary. Adv Data (328):1–32Google Scholar
  22. Coombs PG, Heck M, Guhring P, Narus J, Mulhall JP (2012) A review of outcomes of an intracavernosal injection therapy programme. BJU Int 110(11):1787–1791. doi: 10.1111/j.1464-410X.2012.11080.x CrossRefPubMedGoogle Scholar
  23. Corona G, Mannucci E, Mansani R, Petrone L, Bartolini M, Giommi R, Forti G, Maggi M (2004) Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol 46(2):222–228. doi: 10.1016/j.eururo.2004.03.010 CrossRefPubMedGoogle Scholar
  24. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB (2000) Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56(2):302–306CrossRefPubMedGoogle Scholar
  25. Eardley I (2013) The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev 1(1):3–16. doi: 10.1002/smrj.2 CrossRefGoogle Scholar
  26. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, D’Armiento M, Giugliano D (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291(24):2978–2984. doi: 10.1001/jama.291.24.2978 CrossRefPubMedGoogle Scholar
  27. Federal Drug Administration (2007) FDA announces revisions to labels for Cialis, Levitra, and Viagra: potential risk of sudden hearing loss with ED drugs to be displayed more prominently. Retrieved 1 July 2015, from www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109012.htm
  28. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151(1):54–61PubMedGoogle Scholar
  29. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metabol 87(2):589–598. doi: 10.1210/jcem.87.2.8201 CrossRefGoogle Scholar
  30. Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG (2010) Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med 7(1 Pt 2):445–475. doi: 10.1111/j.1743-6109.2009.01624.x CrossRefPubMedGoogle Scholar
  31. Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I (2006) The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med 166(2):213–219. doi: 10.1001/archinte.166.2.213 CrossRefPubMedGoogle Scholar
  32. Guay AT, Perez JB, Jacobson J, Newton RA (2001) Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 22(5):793–797PubMedGoogle Scholar
  33. Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL (2011) The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 171(20):1797–1803. doi: 10.1001/archinternmed.2011.440 CrossRefPubMedGoogle Scholar
  34. Hatzichristou DG, Apostolidis A, Tzortzis V, Ioannides E, Yannakoyorgos K, Kalinderis A (2000) Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 164(4):1197–1200CrossRefPubMedGoogle Scholar
  35. Hatzimouratidis K, Hatzichristou D (2007) Phosphodiesterase type 5 inhibitors: the day after. Eur Urol 51(1):75–88. doi: 10.1016/j.eururo.2006.07.020; discussion 89CrossRefPubMedGoogle Scholar
  36. Inman BA, Sauver JL, Jacobson DJ, McGree ME, Nehra A, Lieber MM, Roger VL, Jacobsen SJ (2009) A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 84(2):108–113. doi: 10.4065/84.2.108 CrossRefPubMedPubMedCentralGoogle Scholar
  37. Jackson G, Rosen RC, Kloner RA, Kostis JB (2006) The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 3(1):28–36. doi: 10.1111/j.1743-6109.2005.00196.x; discussion 36CrossRefPubMedGoogle Scholar
  38. Jankowski JT, Seftel AD, Strohl KP (2008) Erectile dysfunction and sleep related disorders. J Urol 179(3):837–841. doi: 10.1016/j.juro.2007.10.024 CrossRefPubMedGoogle Scholar
  39. Jensen PK, Burnett JK (2002) Erectile dysfunction. Primary care treatment is appropriate and essential. Adv Nurse Pract 10(4):45–47, 51–52PubMedGoogle Scholar
  40. Jensen PK, Lewis J, Jones KB (2004) Improving erectile function: incorporating new guidelines into clinical practice. Adv Nurse Pract 12(4):40–50PubMedGoogle Scholar
  41. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY (2002) Oxygen free radicals and the penis. Expert Opin Pharmacother 3(7):889–897CrossRefPubMedGoogle Scholar
  42. Kaplan SA, Gonzalez RR (2007) Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptoms. Rev Urol 9(2):73–77PubMedPubMedCentralGoogle Scholar
  43. Kendirici M, Bejma J, Hellstrom WJG (2006) Radical prostatectomy and other pelvic surgeries: effects on erectile function. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 135–154CrossRefGoogle Scholar
  44. Kinsey AC, Pomeroy WB, Martin CE (1948) Sexual behavior in the human male. W. B. Saunders, PhiladelphiaGoogle Scholar
  45. Kloner RA, Speakman M (2002) Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep 4(5):397–401CrossRefPubMedGoogle Scholar
  46. Kohler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M (2007) A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 100(4):858–862. doi: 10.1111/j.1464-410X.2007.07161.x CrossRefPubMedGoogle Scholar
  47. Kolodny RC, Kahn CB, Goldstein HH, Barnett DM (1974) Sexual dysfunction in diabetic men. Diabetes 23(4):306–309CrossRefPubMedGoogle Scholar
  48. Kuritzky L, Miner M (2004) Erectile dysfunction assessment and management in primary care practice. In: Broderick G (ed) Oral pharmacotherapy for male sexual dysfunction. Humana Press, Totowa, pp 149–183Google Scholar
  49. LaRochelle JC, Levine L (2006) Evaluation of the patient with erectile dysfunction. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 253–270CrossRefGoogle Scholar
  50. Laumann EO, Paik A, Rosen RC (1999a) The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res 11(Suppl 1):S60–S64CrossRefPubMedGoogle Scholar
  51. Laumann EO, Paik A, Rosen RC (1999b) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281(6):537–544CrossRefPubMedGoogle Scholar
  52. Liu L, Zheng S, Han P, Wei Q (2011) Phosphodiesterase-5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis. Urology 77(1):123–129. doi: 10.1016/j.urology.2010.07.508 CrossRefPubMedGoogle Scholar
  53. Lue TF (2000) Erectile dysfunction. N Engl J Med 342(24):1802–1813. doi: 10.1056/NEJM200006153422407 CrossRefPubMedGoogle Scholar
  54. Matsumoto AM (2002) Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57:M76–M99CrossRefPubMedGoogle Scholar
  55. Mazzola C, Mulhall JP (2011) Penile rehabilitation after prostate cancer treatment: outcomes and practical algorithm. Urol Clin N Am 38(2):105–118. doi: 10.1016/j.ucl.2011.03.002 CrossRefGoogle Scholar
  56. McCullough AR (2001) Prevention and management of erectile dysfunction following radical prostatectomy. Urol Clin North Am 28(3):613–627CrossRefPubMedGoogle Scholar
  57. McCullough AR (2003) The penis as a barometer of endothelial health. Rev Urol 5(Suppl 7):S3–S8PubMedPubMedCentralGoogle Scholar
  58. McCullough AR (2008) Rehabilitation of erectile function following radical prostatectomy. Asian J Androl 10(1):61–74. doi: 10.1111/j.1745-7262.2008.00366.x CrossRefPubMedGoogle Scholar
  59. McMahon CG (2004) Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med 1:292–300CrossRefPubMedGoogle Scholar
  60. Meda Pharmaceuticals Inc. (2014) MUSE full prescribing information. Retrieved 23 Oct 2016, from http://www.muserx.com/hcp/global/full-prescribing-information.aspx
  61. Montague DK, Jarrow JP, Broderick GA, Dmochoski RR, Heaton JP, Lue TF, Milbank AJ, Nehra A, Sharlip ID (2005) Erectile dysfunction guideline update panel: the management of erectile dysfunction. J Urol 174(1):230–239Google Scholar
  62. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol 158(4):1408–1410CrossRefPubMedGoogle Scholar
  63. Montorsi F, Maga T, Strambi LF, Salonia A, Barbieri L, Scattoni V, Guazzoni G, Losa A, Rigatti P, Pizzini G (2000) Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study. Urology 56(6):906–911CrossRefPubMedGoogle Scholar
  64. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C (2008) Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 54(4):924–931. doi: 10.1016/j.eururo.2008.06.083 CrossRefPubMedGoogle Scholar
  65. Mulhall JP (2008) Penile rehabilitation following radical prostatectomy. Curr Opin Urol 18(6):613–620. doi: 10.1097/MOU.0b013e3283136462 CrossRefPubMedGoogle Scholar
  66. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2(4):532–540. doi: 10.1111/j.1743-6109.2005.00081_1.x; discussion 540–542CrossRefPubMedGoogle Scholar
  67. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G (2010) Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 7(4 Pt 2):1687–1698. doi: 10.1111/j.1743-6109.2010.01804.x CrossRefPubMedGoogle Scholar
  68. Mydlo JH, Viterbo R, Crispen P (2005) Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy. BJU Int 95(6):843–846. doi: 10.1111/j.1464-410X.2005.05413.x CrossRefPubMedGoogle Scholar
  69. Nehra A, Jackson G, Miner M, Billups KL, Burnett AL, Buvat J, Carson CC, Cunningham GR, Ganz P, Goldstein I, Guay AT, Hackett G, Kloner RA, Kostis J, Montorsi P, Ramsey M, Rosen R, Sadovsky R, Seftel AD, Shabsigh R, Vlachopoulos C, Wu FC (2012) The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 87(8):766–778. doi: 10.1016/j.mayocp.2012.06.015 CrossRefPubMedPubMedCentralGoogle Scholar
  70. NIH Consensus Panel on Impotence (1993) Impotence. NIH Consensus Development Panel on Impotence. JAMA 270(1):83–90CrossRefGoogle Scholar
  71. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, Giuliano F, Brock G, Study Group (2008) Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 20(5):479–486. doi: 10.1038/ijir.2008.33 CrossRefPubMedGoogle Scholar
  72. Pahlajani G, Raina R, Jones S, Ali M, Zippe C (2012) Vacuum erection devices revisited: its emerging role in the treatment of erectile dysfunction and early penile rehabilitation following prostate cancer therapy. J Sex Med 9(4):1182–1189. doi: 10.1111/j.1743-6109.2010.01881.x CrossRefPubMedGoogle Scholar
  73. Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ (2013) Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int 112(6):844–851. doi: 10.1111/bju.12253 CrossRefPubMedGoogle Scholar
  74. Porst H, Giuliano F, Glina S, Ralph D, Casabe AR, Elion-Mboussa A, Shen W, Whitaker JS (2006) Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 50(2):351–359. doi: 10.1016/j.eururo.2006.02.052 CrossRefPubMedGoogle Scholar
  75. Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S, Hellstrom W, Martin-Morales A, Salonia A, Sharlip I, ISSM Standards Committee for Sexual Medicine (2013) SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10(1):130–171. doi: 10.1111/jsm.12023 CrossRefPubMedGoogle Scholar
  76. Pritzker MR (1999) The penile stress test: a window to the hearts of man? Circ J 100(Suppl 1):3751Google Scholar
  77. Rabbani F, Schiff J, Piecuch M, Yunis LH, Eastham JA, Scardino PT, Mulhall JP (2010) Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years? J Sex Med 7(12):3984–3990. doi: 10.1111/j.1743-6109.2010.01969.x CrossRefPubMedGoogle Scholar
  78. Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD (2005) Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy. Urology 65(2):360–364. doi: 10.1016/j.urology.2004.09.013 CrossRefPubMedGoogle Scholar
  79. Raina R, Agarwal A, Ausmundson S, Lakin M, Nandipati KC, Montague DK, Mansour D, Zippe CD (2006) Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function. Int J Impot Res 18(1):77–81. doi: 10.1038/sj.ijir.3901380 CrossRefPubMedGoogle Scholar
  80. Raina R, Pahlajani G, Agarwal A, Zippe CD (2008) Early penile rehabilitation following radical prostatectomy: Cleveland clinic experience. Int J Impot Res 20(2):121–126. doi: 10.1038/sj.ijir.3901573 CrossRefPubMedGoogle Scholar
  81. Rhoden EL, Ribeiro EP, Teloken C, Souto CA (2005) Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int 96(6):867–870. doi: 10.1111/j.1464-410X.2005.05728.x CrossRefPubMedGoogle Scholar
  82. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326CrossRefPubMedGoogle Scholar
  83. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O’Leary MP, Puppo P, Robertson C, Giuliano F (2003) Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44(6):637–649CrossRefPubMedGoogle Scholar
  84. Rowland DL, Incrocci L, Slob AK (2005) Aging and sexual response in the laboratory in patients with erectile dysfunction. J Sex Marital Ther 31(5):399–407. doi: 10.1080/00926230591006520 CrossRefPubMedGoogle Scholar
  85. Sachs BD (2003) The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction. Int J Impot Res 15(1):72–78. doi: 10.1038/sj.ijir.3900952 CrossRefPubMedGoogle Scholar
  86. Sadovsky R, Curtis K (2006) How a primary care clinician approaches erectile dysfunction. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 77–104CrossRefGoogle Scholar
  87. Seftel AD, Sundi P, Swindle R (2004) The prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 171:2341–2345CrossRefPubMedGoogle Scholar
  88. Selvin E, Burnett AL, Platz EA (2007) Prevalence and risk factors for erectile dysfunction in the US. Am J Med 120(2):151–157. doi: 10.1016/j.amjmed.2006.06.010 CrossRefPubMedGoogle Scholar
  89. Sesti C, Florio V, Johnson EG, Kloner RA (2007) The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res 19:55–61CrossRefPubMedGoogle Scholar
  90. Shabsigh R (2006) Epidemiology of erectile dysfunction. In: Mulcahy JJ (ed) Male sexual function: a guide to clinical management, 2nd edn. Humana Press, Totowa, pp 47–59CrossRefGoogle Scholar
  91. Shamloul R, Ghanem H (2013) Erectile dysfunction. Lancet 381(9861):153–165. doi: 10.1016/S0140-6736(12)60520-0 CrossRefPubMedGoogle Scholar
  92. Stember DS, Mulhall JP (2012) The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer. Brachytherapy 11(2):87–96. doi: 10.1016/j.brachy.2012.01.002 CrossRefPubMedGoogle Scholar
  93. Tal R, Teloken P, Mulhall JP (2011) Erectile function rehabilitation after radical prostatectomy: practice patterns among AUA members. J Sex Med 8(8):2370–2376. doi: 10.1111/j.1743-6109.2011.02355.x CrossRefPubMedGoogle Scholar
  94. Teloken PE, Smith EB, Lodowsky C, Freedom T, Mulhall JP (2006) Defining association between sleep apnea syndrome and erectile dysfunction. Urology 67(5):1033–1037. doi: 10.1016/j.urology.2005.11.040 CrossRefPubMedGoogle Scholar
  95. Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y, EAU (2006) EAU Guidelines on erectile dysfunction: an update. Eur Urol 49(5):806–815. doi: 10.1016/j.eururo.2006.01.028 CrossRefPubMedGoogle Scholar
  96. Zias N, Bezwada V, Gilman S, Chroneou A (2009) Obstructive sleep apnea and erectile dysfunction: still a neglected risk factor? Sleep Breath 13(1):3–10. doi: 10.1007/s11325-008-0212-8 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Veterans AffairsOffice of Nursing ServicesWashingtonUSA
  2. 2.Sexual HealthJohn & Carol Walter Center for Urological Health, North Shore University Health SystemGlenviewUSA

Personalised recommendations